Breast Cancer Research and Treatment

, Volume 12, Issue 1, pp 83–86 | Cite as

Brain metastases from breast cancer may respond to endocrine therapy

  • Ramón Colomer
  • Darío Casas
  • José M. Del Campo
  • Merçé Boada
  • Diego Rubio
  • Luis Salvador
Correspondence

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carey RW, Davis JM, Zervas NT. Tamoxifen-induced regression of cerebral metastases in breast carcinoma. Cancer Treat Reports 65: 793–795, 1981Google Scholar
  2. 2.
    Sparrow GEA, Rubens RD. Brain metastases from breast cancer: clinical course, prognosis and influence of treatment. Clin Oncol 7: 291–301, 1981PubMedGoogle Scholar
  3. 3.
    Grisoli F, Vincentelli F, Foa J, Lavail G, Salamon G. Effect of bromocriptine on brain metastasis in breast cancer. Lancet ii: 745–746, 1981Google Scholar
  4. 4.
    Hansen SB, Galsgård H, von Eyben FE, Westergaard-Nielsen V, Wolf-Jensen J. Tamoxifen for brain metastases from breast cancer. Ann Neurol 20: 544, 1986Google Scholar
  5. 5.
    Tsukada Y, Fouad A, Pickren JW, Lanne WW. Central nervous system metastasis from breast carcinoma: autopsy study. Cancer 52: 2349–2354, 1983PubMedGoogle Scholar
  6. 6.
    DiStefano A, Yap HY, Hortobagyi GN, Blumenschein GR. The natural history of breast cancer patients with brain metastases. Cancer 44: 1913–1918, 1979PubMedGoogle Scholar
  7. 7.
    Austin GE, Hiesiger EM, Lipshultz L, Basler GA, Posner JB, Shapiro WR. Temporal changes in brain tumor capillary permeability after dexamethasone: a quantitative autoradiographic study in rat C6 gliomas. Neurology 35 (suppl 1): 288, 1985Google Scholar
  8. 8.
    Lippman ME, Bolan G, Huff K. The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4602–4609, 1976PubMedGoogle Scholar
  9. 9.
    Borgelt B, Gelber R, Kramer S,et al.: The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Rad Oncol Biol Phys 6: 1–9, 1980Google Scholar
  10. 10.
    Rosner D, Nemeto T, Lane WW. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 58: 832–839, 1986PubMedGoogle Scholar
  11. 11.
    Slatkin NE, Wasserstrom WR, Posner JB. Response of brain metastasis to systemic chemotherapy. Neurology 35 (suppl 1): 112, 1985PubMedGoogle Scholar
  12. 12.
    Grau de Castro JJ, Estapé J, Daniels M, Santabárbara P, Tarragó E. Tratamiento de las metastasis cerebrales con BCNU y VM26. Neoplasia (Barc) 4: 145–149, 1987Google Scholar
  13. 13.
    Mende S, Blichner F, Stoeter P, Meuret G. Erfolgreiche Behandlung von Hirnmetastasen bei Mamma-karzinom mit nicht liquorgangigen Zytostatika und Hormonen. Onkologie (Basel) 6: 58–61, 1983Google Scholar
  14. 14.
    DiStefano A, Yap HY, Hortobagyi GN, Haynie TP, Blumenschein GR. The natural history of patients with breast carcinoma metastatic to the brain. Proc AACR/ASCO 19: 334, 1978Google Scholar
  15. 15.
    Muller W, Kretzschmar K, Schicketanz K-H. CT-analyses of cerebral tumors under steroid therapy. Neuroradiology 26: 293–29, 1984PubMedGoogle Scholar
  16. 16.
    Powles TJ. Present role of hormonal therapy. In: Bonadonna G, (ed) Breast Cancer Diagnosis and Treatment. Chichester: John Wiley & Sons, 229–246, 1984Google Scholar
  17. 17.
    Stewart JF, King RJB, Sexton SA, Millis RR, Rubens RD, Hayward JL. Oestrogen receptors, sites of metastatic disease and survival in metastatic breast cancer. Eur J Cancer 17: 449–453, 1981PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • Ramón Colomer
    • 1
  • Darío Casas
    • 2
  • José M. Del Campo
    • 1
  • Merçé Boada
    • 3
  • Diego Rubio
    • 1
  • Luis Salvador
    • 4
  1. 1.Medical OncologyValle de Hebrón HospitalBarcelonaSpain
  2. 2.RadiologyValle de Hebrón HospitalBarcelonaSpain
  3. 3.NeurologyValle de Hebrón HospitalBarcelonaSpain
  4. 4.Radiation Therapy UnitsValle de Hebrón HospitalBarcelonaSpain
  5. 5.Medicine Branch, National Cancer InstituteNational Institutes of HealthBethesdaUSA

Personalised recommendations